AU601168B2 - Novel cell growth regulatory factor - Google Patents

Novel cell growth regulatory factor Download PDF

Info

Publication number
AU601168B2
AU601168B2 AU66608/86A AU6660886A AU601168B2 AU 601168 B2 AU601168 B2 AU 601168B2 AU 66608/86 A AU66608/86 A AU 66608/86A AU 6660886 A AU6660886 A AU 6660886A AU 601168 B2 AU601168 B2 AU 601168B2
Authority
AU
Australia
Prior art keywords
polypeptide
cells
amino acid
proliferation
oncostatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU66608/86A
Other languages
English (en)
Other versions
AU6660886A (en
Inventor
Thomas J. Brown
Marcia B. Hanson
Mario N. Lioubin
Hans Marquardt
Mohammed Shoyab
Joyce M. Zarling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU6660886A publication Critical patent/AU6660886A/en
Application granted granted Critical
Publication of AU601168B2 publication Critical patent/AU601168B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU66608/86A 1985-12-20 1986-12-16 Novel cell growth regulatory factor Expired AU601168B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US93528386A 1986-11-26 1986-11-26
US935283 1986-11-26
US811235 1986-11-26

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU67765/90A Division AU639048B2 (en) 1985-12-20 1990-12-05 Novel cell growth regulatory factor

Publications (2)

Publication Number Publication Date
AU6660886A AU6660886A (en) 1987-06-25
AU601168B2 true AU601168B2 (en) 1990-09-06

Family

ID=27123452

Family Applications (2)

Application Number Title Priority Date Filing Date
AU66608/86A Expired AU601168B2 (en) 1985-12-20 1986-12-16 Novel cell growth regulatory factor
AU67765/90A Ceased AU639048B2 (en) 1985-12-20 1990-12-05 Novel cell growth regulatory factor

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU67765/90A Ceased AU639048B2 (en) 1985-12-20 1990-12-05 Novel cell growth regulatory factor

Country Status (29)

Country Link
JP (1) JP2559035B2 (it)
KR (1) KR920005920B1 (it)
CN (1) CN1017626B (it)
AT (1) AT400444B (it)
AU (2) AU601168B2 (it)
BE (1) BE905957A (it)
CA (1) CA1340296C (it)
CH (1) CH675727A5 (it)
CY (1) CY1608A (it)
DE (2) DE3643428A1 (it)
DK (1) DK174094B1 (it)
ES (1) ES2003180A6 (it)
FI (1) FI91484C (it)
FR (1) FR2597108B1 (it)
GB (1) GB2185485B (it)
GR (1) GR862936B (it)
HK (1) HK65691A (it)
HU (1) HU210694B (it)
IE (1) IE59415B1 (it)
IL (1) IL81017A (it)
IT (1) IT1213428B (it)
LU (1) LU86718A1 (it)
NL (1) NL8603209A (it)
NO (1) NO174556C (it)
NZ (1) NZ218634A (it)
OA (1) OA08494A (it)
PT (1) PT83986B (it)
SE (1) SE505059C2 (it)
SG (1) SG60891G (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
NZ237533A (en) * 1990-03-29 1992-12-23 Bristol Myers Squibb Co Monoclonal antibodies which bind to oncostatin m, cell lines producing them
ZA912137B (en) * 1990-03-29 1992-11-25 Oncogen Monocional antibodies that inhibit growth of kaposi's sarcoma
WO1992002556A1 (en) * 1990-08-02 1992-02-20 Michael Valentine Agrez Human colon cancer cell-derived fibroblast elongation factor
ZA936925B (en) * 1992-09-25 1995-03-20 Lilly Co Eli Modified platelet factor-4.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4235485A (en) * 1984-03-23 1985-11-01 Oncogen Platelet related growth regulator
GB2185485A (en) * 1985-12-20 1987-07-22 Oncogen Cell growth regulatory factor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4235485A (en) * 1984-03-23 1985-11-01 Oncogen Platelet related growth regulator
GB2185485A (en) * 1985-12-20 1987-07-22 Oncogen Cell growth regulatory factor

Also Published As

Publication number Publication date
GB2185485A (en) 1987-07-22
NL8603209A (nl) 1987-07-16
NO865178L (no) 1987-06-22
GB8629997D0 (en) 1987-01-28
FR2597108B1 (fr) 1991-02-15
IL81017A0 (en) 1987-03-31
FI91484C (fi) 1994-07-11
OA08494A (fr) 1988-07-29
AU639048B2 (en) 1993-07-15
AU6660886A (en) 1987-06-25
DK615386D0 (da) 1986-12-18
HUT43103A (en) 1987-09-28
SE8605459D0 (sv) 1986-12-18
KR870005645A (ko) 1987-07-06
LU86718A1 (fr) 1988-07-14
SE505059C2 (sv) 1997-06-16
CA1340296C (en) 1998-12-29
HU210694B (en) 1995-06-28
PT83986A (en) 1987-01-01
NO174556B (no) 1994-02-14
JPS62236498A (ja) 1987-10-16
DE3645095C2 (de) 1993-11-18
ATA340686A (de) 1995-05-15
IT1213428B (it) 1989-12-20
DE3643428C2 (it) 1990-08-23
KR920005920B1 (ko) 1992-07-24
DK615386A (da) 1987-06-21
GB2185485B (en) 1990-07-04
DE3643428A1 (de) 1987-09-24
FR2597108A1 (fr) 1987-10-16
IL81017A (en) 1993-01-14
CN1017626B (zh) 1992-07-29
AT400444B (de) 1995-12-27
IE863345L (en) 1987-06-20
AU6776590A (en) 1991-03-14
FI91484B (fi) 1994-03-31
HK65691A (en) 1991-08-23
IE59415B1 (en) 1994-02-23
NZ218634A (en) 1991-06-25
CH675727A5 (it) 1990-10-31
CY1608A (en) 1992-04-03
FI865156A (fi) 1987-06-21
FI865156A0 (fi) 1986-12-17
JP2559035B2 (ja) 1996-11-27
BE905957A (fr) 1987-06-17
SE8605459L (sv) 1987-06-21
IT8622787A0 (it) 1986-12-19
CN86108955A (zh) 1987-12-02
NO865178D0 (no) 1986-12-19
NO174556C (no) 1994-05-25
ES2003180A6 (es) 1988-10-16
SG60891G (en) 1991-08-23
PT83986B (pt) 1989-07-31
DK174094B1 (da) 2002-06-10
GR862936B (en) 1987-10-28

Similar Documents

Publication Publication Date Title
US4816561A (en) Biologically active polypeptides
US5240912A (en) Transforming growth factor (TGF) peptides
US4863899A (en) Biologically active polypeptides
PT86885B (pt) Processo de preparacao de compostos que inibem o crescimento de celulas neoplasticas para utilizacao no tratamento de doencas cancerigenas
AU601168B2 (en) Novel cell growth regulatory factor
US5428012A (en) Oncostatin M and novel compositions having anti-neoplastic activity
EP0290948A2 (en) Oncostatin M and novel compositions having anti-neoplastic activity
IE56089B1 (en) Lymphocyte growth factor
AU689560B2 (en) Method for stimulating profileration of colon cells using POMC-76-103
CA1341535C (en) Transforming growth factor peptides
AU603053B2 (en) Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses
US5071956A (en) Protein with vascular activity derived from monocytes and its analogues, a process for its extraction and their uses for therapeutic purposes and for the preparation of antibodies
FI98373B (fi) Uusi diagnostisesti käyttökelpoinen polypeptidi, onkostatiini M
EP0234545A2 (en) Purified human angiogenic factor, method for its preparation and pharmaceutical preparations
CA1341536C (en) Transforming growth factor peptides
WO1989010133A1 (en) Stem cell inhibitors
NZ231140A (en) Transforming growth factor (tgf) and its isolation